Indeed, an inhibitory effect of ERβ agonists on AR activity, cell proliferation, and tumor growth have been demonstrated8,28,31,58, and activation of ERβ also appears to enhance the effect of androgen deprivation therapy in an experimental system59. This evidence concerns the gene ESR2 and neoplasm.